Publications by authors named "Kelly Faulk"

Claim this Profile
A
Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1.
Kelly E Faulk, John A Kairalla, Emily Hibbitts, Janel Long-Boyle, Meenakshi Devidas

Blood Adv· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal Premedication Does Not Impact Transition to Short-acting Asparaginase or Incidence of Hypersensitivity to Pegylated Asparaginase: A Single-institution Experience.
Lindsey A Murphy, Zanette K Bradley, Allie N Elozory, Dexiang Gao, Kelly E Faulk

J Pediatr Hematol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pediatric case of -rearranged B-lymphoblastic lymphoma treated with high-risk therapy.
Lindsey Murphy, Bradford Siegele, Billie Carstens, Lisa Hartman, Kelly Faulk

Leuk Lymphoma· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Kelly E Faulk, John A Kairalla, ZoAnn E Dreyer, Andrew J Carroll, Nyla A Heerema

Pediatr Blood Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.
Laurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, Sung K Chiu, Vincent Kuek, Kelly E Faulk

Leukemia· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience.
Cassandra Rush, Kelly E Faulk, Zanette Kanani Bradley, Aubree Turner, Maija Krumins

J Allergy Clin Immunol Pract· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials 2004-2015.
Kelly E Faulk, Amy Anderson-Mellies, Myles Cockburn, Adam L Green

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin.
Kelly E Faulk, Jenna M Sopfe, Kristen Campbell, Deborah R Liptzin, Arthur K Liu

Br J Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.
Kelly Faulk, Lia Gore, Todd Cooper

Paediatr Drugs· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis